SJ Medical
SJ Medical
Advanced medical equipment selected for specialized clinical centers and chronic patient rehabilitation in Damascus.
Chronic Total Occlusion (CTO) represents the peak of complexity in interventional cardiology. Defined as a complete coronary artery obstruction showing TIMI (Thrombolysis in Myocardial Infarction) grade 0 flow, with an estimated duration of three months or longer, CTO has traditionally been the leading reason for referring patients for coronary artery bypass graft (CABG) surgery rather than percutaneous coronary intervention (PCI). Resolving these calcified, collagen-rich plaques demands specialized interventional equipment designed for extreme torque transmission, crossability, and high puncture force resistance.
"Successful CTO percutaneous coronary intervention relies on a triad of physician expertise, tactical clinical strategies (such as retrograde tracking and antegrade dissection re-entry), and premium-grade microcatheters and guidewires. Ensuring access to high-caliber devices is paramount to boosting procedural success rates beyond 85-90%."
CTO lesions are histologically characterized by dense collagenous tissue, intracellular lipids, calcium deposits, and variable degrees of neovascularization. The proximal cap is often calcified and blunt, presenting a formidable barrier to conventional guidewires. Microchannels, while present in some occlusions, are frequently too narrow or tortuous to guide standard catheters. Consequently, specialized coronary balloon dilatation catheters and robust guidewires with hydrophilic coatings are required to cross the lesion safely without causing vessel dissection or perforation.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop (Class 100,000) with localized hundred-class (Class 100) areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments. Each product is developed with an emphasis on precision, safety, and clinical performance, aiming to support physicians in achieving optimal procedural outcomes.
The company’s products are widely applied in minimally invasive procedures involving both coronary and peripheral vascular systems. They play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery.
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating its strong commitment to product quality and compliance.
We have established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Our products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt, among others. The company continues to expand its international footprint and strengthen its global presence, with a particular focus on developing clinical hubs like the Damascus healthcare market.
Meeting the rising demand for cardiovascular interventional therapy in Syria's clinical centers.
The healthcare infrastructure in Damascus, Syria, is undergoing a phase of restructuring and modernization. As coronary artery disease (CAD) remains a primary cause of mortality in the Levant region, local hospitals and specialized clinics are actively upgrading their catheterization laboratories (Cath Labs). Key tertiary facilities—including Damascus University Hospitals, Al-Assad University Hospital, and various private cardiology clinics—are seeing an influx of patients requiring complex percutaneous coronary interventions (PCIs).
However, the local commercial reality presents distinct challenges. Procurement departments in Damascus face logistical and regulatory hurdles, necessitating reliable partnerships with ISO 13485 certified manufacturers who can navigate import logistics and provide consistent supply chains. High-quality CTO devices (such as microcatheters, guidewires, and high-pressure balloon dilatation catheters) are highly sought after to minimize procedural risks and avoid high-risk open-heart surgeries.
SJ Medical works closely with regional distributors in the Middle East to offer flexible supply strategies, ensuring that Syrian interventional cardiologists have access to state-of-the-art balloon catheters and guidewires. By providing comprehensive clinical documentation and regulatory files, we help local partners expedite import approvals with the Syrian Ministry of Health.
For international hospital groups, medical device distributors, and OEM partners, procuring vascular interventional devices involves strict risk assessments. SJ Medical addresses these critical enterprise needs through a series of robust operational and manufacturing protocols:
By offering customized OEM/ODM options, SJ Medical enables global buyers to tailor balloon lengths, diameters, and shaft coatings to meet specific clinical preferences in their target markets.
The field of CTO intervention is moving rapidly toward miniaturization and specialized surface treatments. SJ Medical's engineering team is actively pursuing research in several frontier technologies:
Developing balloon catheters with crossing profiles below 0.016 inches to navigate severe calcified stenoses.
Optimizing durable hydrophilic coatings that maintain lubricity during prolonged, high-friction procedures.
R&D on multi-functional microcatheters designed specifically for retrograde wire escalation techniques.
Our long-term clinical objective is to bridge the gap between complex interventional devices and affordable healthcare, enabling hospitals in developing markets like Damascus to treat coronary diseases with high success rates and low complication rates.
Broad-spectrum rehabilitation, pain management, and microcirculation therapy systems.
Direct answers regarding clinical trials, regulatory clearance, and Damascus market distribution.
